{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"relapsed-refractory-diffuse-large-b-cell-lymphoma","columns":[{"gene":"","key":"population-8dc490d21b3158868aca","label":"relapsed/refractory diffuse large B-cell lymphoma","mondoId":"MONDO:0000901","onsetQualifier":null,"originColumnKey":"MONDO:0000901/no-native-evidence","originalViews":[{"key":"MONDO:0000901/no-native-evidence","label":"relapsed/refractory diffuse large B-cell lymphoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8dc490d21b3158868aca"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-8dc490d21b3158868aca"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A diffuse large B-cell lymphoma characterized by less than 50 percent decrease in lesion size with induction therapy or the appearance of new lesions or the appearance of new lesions after attainment of complete remission.","mondoId":"MONDO:0000901","node":{"canonicalSlug":"relapsed-refractory-diffuse-large-b-cell-lymphoma","comparisons":[{"documentSha256":"82b9d7d66fb4babefb26e844950ee36a7dd8627565ca35cf9151cfec05b08424","key":"expanded-aggressive-b-cell-non-hodgkin-lymphoma","kind":"expanded","label":"aggressive B-cell non-Hodgkin lymphoma","memberIds":["MONDO:0000814","MONDO:0000872","MONDO:0000901","MONDO:0006117","MONDO:0006150","MONDO:0006158","MONDO:0006223","MONDO:0006225","MONDO:0006268","MONDO:0006383","MONDO:0006387","MONDO:0006416","MONDO:0006417","MONDO:0006428","MONDO:0006430","MONDO:0006462","MONDO:0007243","MONDO:0017346","MONDO:0017347","MONDO:0017595","MONDO:0017596","MONDO:0017597","MONDO:0017601","MONDO:0018225","MONDO:0018813","MONDO:0018842","MONDO:0018876","MONDO:0018905","MONDO:0019461","MONDO:0019466","MONDO:0020323","MONDO:0020324","MONDO:0020511","MONDO:0044889","MONDO:0850418","MONDO:0850419","MONDO:0850468","MONDO:0850469","MONDO:0850470","MONDO:0850471","MONDO:0850472","MONDO:0850473","MONDO:0859747","MONDO:0859748","MONDO:0859749","MONDO:0956987","MONDO:0956988","MONDO:0979292"],"mondoId":"MONDO:0017595","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-82b9d7d66fb4babefb26.82b9d7d66fb4babefb26e844950ee36a7dd8627565ca35cf9151cfec05b08424.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"relapsed/refractory diffuse large B-cell lymphoma","paragraphs":["A diffuse large B-cell lymphoma characterized by less than 50 percent decrease in lesion size with induction therapy or the appearance of new lesions or the appearance of new lesions after attainment of complete remission."],"scope":"exact","source":"MONDO","upstream":"DOID:0080192, PMID:22160081","url":"https://monarchinitiative.org/MONDO:0000901"},"ownColumnKeys":["population-8dc490d21b3158868aca"],"publication":"published","relationships":[{"kind":"parent","label":"diffuse large B-cell lymphoma","mondoId":"MONDO:0018905","slug":"diffuse-large-b-cell-lymphoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/22843"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0000901\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0080192, PMID:22160081</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A diffuse large B-cell lymphoma characterized by less than 50 percent decrease in lesion size with induction therapy or the appearance of new lesions or the appearance of new lesions after attainment of complete remission.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0000901\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"relapsed-refractory-diffuse-large-b-cell-lymphoma","sourceDocuments":[{"name":"MONDO: relapsed/refractory diffuse large B-cell lymphoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0000901"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"relapsed/refractory diffuse large B-cell lymphoma"},"schemaVersion":1}
